NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,890,000 | -43.3% | 109,330 | -46.5% | 0.04% | -43.1% |
| Q1 2019 | $6,865,000 | -29.8% | 204,330 | -31.3% | 0.06% | -36.3% |
| Q4 2018 | $9,774,000 | -53.8% | 297,330 | -14.4% | 0.10% | -42.7% |
| Q3 2018 | $21,173,000 | +75.5% | 347,330 | +40.6% | 0.18% | +61.8% |
| Q2 2018 | $12,061,000 | -42.6% | 246,997 | +24.9% | 0.11% | -47.6% |
| Q1 2018 | $21,016,000 | -18.3% | 197,777 | -54.1% | 0.21% | -19.2% |
| Q4 2017 | $25,726,000 | +133.5% | 430,777 | -6.1% | 0.26% | +108.0% |
| Q3 2017 | $11,016,000 | +22.8% | 458,997 | 0.0% | 0.12% | +12.6% |
| Q2 2017 | $8,973,000 | -4.2% | 458,997 | +15.0% | 0.11% | -13.3% |
| Q1 2017 | $9,364,000 | +78.7% | 398,997 | -6.6% | 0.13% | +54.2% |
| Q4 2016 | $5,240,000 | -28.6% | 427,098 | 0.0% | 0.08% | -37.6% |
| Q3 2016 | $7,338,000 | +5.3% | 427,098 | -12.8% | 0.13% | -5.7% |
| Q2 2016 | $6,971,000 | +3.5% | 489,893 | 0.0% | 0.14% | -6.0% |
| Q1 2016 | $6,736,000 | +0.5% | 489,893 | +23.1% | 0.15% | -18.0% |
| Q4 2015 | $6,705,000 | +53.7% | 397,905 | 0.0% | 0.18% | +53.8% |
| Q3 2015 | $4,361,000 | -4.5% | 397,905 | +9.0% | 0.12% | +7.2% |
| Q2 2015 | $4,565,000 | +13.7% | 364,905 | 0.0% | 0.11% | +6.7% |
| Q1 2015 | $4,014,000 | +1397.8% | 364,905 | +2009.3% | 0.10% | +1385.7% |
| Q4 2014 | $268,000 | +28.2% | 17,300 | 0.0% | 0.01% | +16.7% |
| Q3 2014 | $209,000 | -5.9% | 17,300 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $222,000 | +5.7% | 17,300 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $210,000 | +7.1% | 17,300 | 0.0% | 0.01% | +16.7% |
| Q4 2013 | $196,000 | -52.1% | 17,300 | -55.9% | 0.01% | -53.8% |
| Q3 2013 | $409,000 | +104.5% | 39,189 | +126.5% | 0.01% | -75.9% |
| Q2 2013 | $200,000 | – | 17,300 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |